bluebird bio, Inc.
BLUE · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $39 | $39 | $11 | $16 |
| % Growth | 0.5% | 263% | -34.1% | – |
| Cost of Goods Sold | $12 | $23 | $12 | $29 |
| Gross Profit | $26 | $16 | -$1 | -$13 |
| % Margin | 68.4% | 40.8% | -11% | -79.8% |
| R&D Expenses | $18 | $21 | $23 | $25 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $30 | $31 | $40 | $50 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3 | -$0 | $3 | $0 |
| Operating Expenses | $51 | $52 | $66 | $76 |
| Operating Income | -$25 | -$36 | -$67 | -$88 |
| % Margin | -63.6% | -94.6% | -630.6% | -549% |
| Other Income/Exp. Net | -$4 | $8 | $6 | $7 |
| Pre-Tax Income | -$29 | -$29 | -$61 | -$81 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$29 | -$29 | -$61 | -$81 |
| % Margin | -75.1% | -74.5% | -573% | -505.5% |
| EPS | -2.98 | -0.45 | -0.95 | -1.27 |
| % Growth | -562.2% | 52.6% | 25.2% | – |
| EPS Diluted | -2.98 | -0.45 | -0.95 | -1.27 |
| Weighted Avg Shares Out | 10 | 64 | 64 | 64 |
| Weighted Avg Shares Out Dil | 10 | 64 | 64 | 64 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $2 | $3 |
| Interest Expense | $6 | $6 | $6 | $5 |
| Depreciation & Amortization | $16 | $14 | $15 | $17 |
| EBITDA | -$8 | -$9 | -$40 | -$59 |
| % Margin | -19.8% | -23.4% | -374.5% | -368.9% |